Evidence map›Paper›PMID 39257653›Full record

ArticleRSC advances2024

Synthesis, kinetics, mechanisms, and bioactivity evaluations of a novel Zn(ii) complex.

Anwesha Dey, Ramesh Kumar, Bhramar Dutta, Rajib Bandopadhyay, Sankha Chakrabortty, Moonis Ali Khan, Rijuta Ganesh Saratale, Ganesh Dattatraya Saratale, Byong Hun Jeon, Alak K Ghosh

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anwesha DeyDepartment of Chemistry, The University of Burdwan Burdwan (E) 713104 West Bengal India akghosh@chem.buruniv.ac.in.
Ramesh KumarDepartment of Earth Resources & Environmental, Engineering, Hanyang University 222-Wangsimni-ro, Seongdong-gu Seoul 04763 Republic of Korea bhjeon@hanyang.ac.kr.ORCID https://orcid.org/0000-0002-7150-4404
Bhramar DuttaDepartment of Botany, The University of Burdwan Burdwan (E) 713104 West Bengal India.ORCID https://orcid.org/0000-0003-1694-0366
Rajib BandopadhyayDepartment of Botany, The University of Burdwan Burdwan (E) 713104 West Bengal India.
Sankha ChakraborttySchool of Chemical Engineering, Kalinga Institute of Industrial Technology Bhubaneswar 751024 Odisha India.ORCID https://orcid.org/0000-0001-7719-8586
Moonis Ali KhanChemistry Department, College of Science, King Saud University Riyadh 11451 Saudi Arabia.ORCID https://orcid.org/0000-0002-0548-8581
Rijuta Ganesh SarataleResearch Institute of Integrative Life Sciences, Dongguk University-Seoul Ilsandong-gu Goyang-si Gyeonggido 10326 Republic of Korea.
Ganesh Dattatraya SarataleDepartment of Food Science and Biotechnology, Dongguk University-Seoul 32 Dongguk-ro, Ilsandong-gu Goyang-si 10326 Gyeonggi-do Republic of Korea.
Byong Hun JeonDepartment of Earth Resources & Environmental, Engineering, Hanyang University 222-Wangsimni-ro, Seongdong-gu Seoul 04763 Republic of Korea bhjeon@hanyang.ac.kr.ORCID https://orcid.org/0000-0002-5478-765X
Alak K GhoshDepartment of Chemistry, The University of Burdwan Burdwan (E) 713104 West Bengal India akghosh@chem.buruniv.ac.in.ORCID https://orcid.org/0000-0003-0540-287X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zn(ii)-based anticancer drugs can be suitable alternatives to conventional Pt(ii)-based drugs because of the unique chemical properties of Zn(ii) and low toxicity. In this study, a new hexadentate and heteroleptic Zn(ii) complex ([Zn(bpy)

Identifiers

PMID39257653
PMCPMC11384325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.